These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31499239)

  • 1. Determinants of alcohol use among people living with HIV initiating isoniazid preventive therapy in Ethiopia.
    Mukherjee TI; Hirsch-Moverman Y; Saito S; Gadisa T; Melaku Z; Howard AA
    Drug Alcohol Depend; 2019 Nov; 204():107465. PubMed ID: 31499239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoniazid preventive therapy use among adult people living with HIV in Zimbabwe.
    Takamiya M; Takarinda K; Balachandra S; Godfrey M; Radin E; Hakim A; Pearson ML; Choto R; Sandy C; Maphosa T; Rogers JH
    Int J STD AIDS; 2021 Oct; 32(11):1020-1027. PubMed ID: 33978529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.
    Sensalire S; Karungi Karamagi Nkolo E; Nabwire J; Lawino A; Kiragga D; Muhire M; Kadama H; Katureebe C; Namuwenge P; Musinguzi J; Calnan J; Seyoum D
    AIDS Res Ther; 2020 May; 17(1):28. PubMed ID: 32460788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
    Robert M; Todd J; Ngowi BJ; Msuya SE; Ramadhani A; Sambu V; Jerry I; Mujuni MR; Mahande MJ; Ngocho JS; Maokola W
    BMC Infect Dis; 2020 Apr; 20(1):276. PubMed ID: 32276618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts.
    Assefa DG; Zeleke ED; Bekele D; Ejigu DA; Molla W; Woldesenbet TT; Aynalem A; Abebe M; Mebratu A; Manyazewal T
    Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis case finding and isoniazid preventive therapy among people living with HIV at public health facilities of Addis Ababa, Ethiopia: a cross-sectional facility based study.
    Denegetu AW; Dolamo BL
    BMC Public Health; 2014 Jan; 14():52. PubMed ID: 24438508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis screening coverage and isoniazid preventive therapy among people living with HIV at Gambella Hospital, southwest Ethiopia: a retrospective study design.
    Aboma M; Dida N
    J Int Med Res; 2021 Sep; 49(9):3000605211046133. PubMed ID: 34551613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and associated factors of tuberculosis among isoniazid users and non-users of HIV patients in Dessie, Ethiopia.
    Mebratu W; Wedajo S; Mohammed S; Endawkie A; Damtew Y
    Sci Rep; 2022 Aug; 12(1):13500. PubMed ID: 35931781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis.
    Geremew D; Endalamaw A; Negash M; Eshetie S; Tessema B
    BMC Infect Dis; 2019 May; 19(1):405. PubMed ID: 31077133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis preventive treatment uptake among people living with HIV during COVID-19 period in Addis Ababa, Ethiopia: a retrospective data review.
    Gebreegziabher SB; Ashuro AA; Kumssa TH; Teferi MY; Alemayue EA; Datiko DG; Yimer SA; Shagre MB
    BMC Infect Dis; 2024 May; 24(1):499. PubMed ID: 38760665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case-control study.
    Alemu YM; Awoke W; Wilder-Smith A
    BMJ Open; 2016 Apr; 6(4):e009058. PubMed ID: 27084271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coverage of isoniazid preventive therapy among people living with HIV; A retrospective cohort study in Tanzania (2012-2016).
    Maokola W; Ngowi B; Lawson L; Robert M; Mahande M; Todd J; Msuya S
    Int J Infect Dis; 2021 Feb; 103():562-567. PubMed ID: 33276111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017).
    Nabity SA; Gunde LJ; Surie D; Shiraishi RW; Kirking HL; Maida A; Auld AF; Odo M; Jahn A; Nyirenda RK; Oeltmann JE
    PLoS One; 2021; 16(4):e0248115. PubMed ID: 33793577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.
    Karanja M; Kingwara L; Owiti P; Kirui E; Ngari F; Kiplimo R; Maina M; Masini E; Onyango E; Ngugi C
    PLoS One; 2020; 15(12):e0234588. PubMed ID: 33264300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.
    Briggs MA; Emerson C; Modi S; Taylor NK; Date A
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S297-305. PubMed ID: 25768869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of adherence to isoniazid preventive therapy in people living with HIV in Ethiopia.
    Ayele HT; van Mourik MS; Bonten MJ
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1342-1347. PubMed ID: 27725045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled trial.
    Chamie G; Hahn JA; Kekibiina A; Emenyonu NI; Beesiga B; Marson K; Fatch R; Lodi S; Adong J; Thirumurthy H; McDonell MG; Gandhi M; Bryant K; Havlir DV; Kamya MR; Muyindike WR
    Lancet Glob Health; 2023 Dec; 11(12):e1899-e1910. PubMed ID: 37973340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Khat use in people living with HIV: a facility-based cross-sectional survey from South West Ethiopia.
    Soboka M; Tesfaye M; Feyissa GT; Hanlon C
    BMC Psychiatry; 2015 Apr; 15():69. PubMed ID: 25879767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.